Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$767,328
New position
Shares Held
6,911
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#169
of 299 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 96%
Shared 0%
None 4%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pathstone Holdings, LLC holds $101,065,916 across 56 Biotechnology names. RYTM ranks #35 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,952 | $22,825,735 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,825 | $8,620,440 | |
| 3 | ASND |
Ascendis Pharma A/S
|
20,248 | $5,400,545 | |
| 4 | CYTK |
Cytokinetics Inc
|
47,633 | $4,057,854 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
15,152 | $3,651,176 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
28,187 | $3,455,162 | |
| 7 | RPRX |
Royalty Pharma plc
|
54,725 | $3,068,429 | |
| 8 | ARGX |
Argenx SE
|
3,094 | $2,870,519 |
All Filings in RYTM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $767,328 | 6,911 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||